International Classification of Headache Disorders-4 – Work in Progress 1
Cephalalgia · 2024
DOI: 10.1177/03331024241233937 ↗Kurz gefasst
Editorial in der Zeitschrift Cephalalgia, 2024. Verfasst von Peter J Goadsby und 10 weiteren Autor:innen. Beteiligte Einrichtung: King's College London, Headache Group, NIHR King's Clinical Research, London, UK. Hauptthemen laut MEDLINE: Headache, Headache Disorders. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 11 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The International Classification of Headache Disorders (ICHD), through its three substantive editions (1–3), has provided the medical community with an invaluable tool that informs clinical practice and frames research efforts. We again (4) acknowledge the very considerable debt to the chair of the first three editions, Professor Jes Olesen, who, with vision and great capability, established the foundation on which we build. ICHD has proven useful in many dimensions. Initially, by necessity, boot-strapped from expert opinion, which will remain a key element of its review and construction, the classification has proved robust in many ways. The ICHD case definitions have provided a foundation for epidemiologic and biological research, which in turn has established headache disorders as very common and disabling (5). To those who argue its biological basis, albeit mirrored in phenotypes (6), one can point to functional imaging data that has identified robust, reproducible, core findings in migraine (7,8) and cluster headache (9). Moreover, ICHD has provided the diagnostic foundation for the development of multiple classes of new migraine treatments, notably serotonin 5-HT 1B/1D receptor agonists, trip-tans; 5-HT 1F receptor agonists, ditans, drugs targeting the calcitonin gene-related peptide (CGRP) pathway, monoclonal antibodies, and receptor antagonists, gepants, neuromodulation devices and most recently, pituitary adenylate cyclase activating polypeptide PACAP blockers (10), all of which are based on pathophysiological knowledge achieved through using iterations
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- King's College London, Headache Group, NIHR King's Clinical Research, London, UK.
- Department of Neurology, University of California, Los Angeles, CA, USA.
- Faculty of Medine, University of Münster, Münster, Germany.
- Department of Neurology, University of California, San Francisco, California, USA.
- Albert Einstein College of Medicine, Bronx, NY, USA.
- University of Hamburg, Hamburg, Germany.
ORCID-Profile: Peter J Goadsby, Stefan Evers, Richard B Lipton, Arne May, Patricia Pozo-Rosich, Jean Schoenen, Cristina Tassorelli, Shuu-Jiun Wang
Zitieren
APA
Goadsby, P. J., Evers, S., Gelfand, A. A., Lipton, R. B., May, A., Pozo-Rosich, P., Schoenen, J., Schwedt, T. J., Tassorelli, C., Terwindt, G., & Wang, S. J. (2024). International Classification of Headache Disorders-4 – Work in Progress 1. Cephalalgia. https://doi.org/10.1177/03331024241233937
Vancouver
Goadsby PJ, Evers S, Gelfand AA, Lipton RB, May A, Pozo-Rosich P, et al. International Classification of Headache Disorders-4 – Work in Progress 1. Cephalalgia. 2024. doi:10.1177/03331024241233937
BibTeX
@article{Goadsby2024,
author = {Goadsby, Peter J and Evers, Stefan and Gelfand, Amy A and Lipton, Richard B and May, Arne and Pozo-Rosich, Patricia and Schoenen, Jean and Schwedt, Todd J and Tassorelli, Cristina and Terwindt, Gisela and Wang, Shuu-Jiun},
title = {International Classification of Headache Disorders-4 – Work in Progress 1},
journal = {Cephalalgia},
year = {2024},
doi = {10.1177/03331024241233937}
}
EUVIMED